Nature Reviews Drug Discovery 14, 369–371 (2015)
In Table 1 of this article, the name of the oncolytic virus being developed by DNAtrix should have read 'DNX-2401'. This has been corrected in the online version of the article.
Additional information
The online version of the original article can be found at 10.1038/nrd4643
Rights and permissions
About this article
Cite this article
Dolgin, E. Erratum: Oncolytic viruses get a boost with first FDA-approval recommendation. Nat Rev Drug Discov 14, 510 (2015). https://doi.org/10.1038/nrd4680
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4680
